Clinical Trials · NCT01155245
Teriparatide (PTH) and Bone Strength in Postmenopausal Women
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- University Health Network, Toronto
- Enrollment
- 60
- Start date
- Jun 2008
- Locations
- 1 site, Canada
- Primary endpoint
- Change in cortical thickness with teriparatide therapy from baseline to 24 months